Nonviral gene delivery to the rat kidney with polyethylenimine

被引:160
作者
Boletta, A
Benigni, A
Lutz, J
Remuzzi, G
Soria, MR
Monaco, L
机构
[1] SAN RAFFAELE SCI INST,DIBIT,I-20132 MILAN,ITALY
[2] MARIO NEGRI INST PHARMACOL RES,I-24100 BERGAMO,ITALY
关键词
D O I
10.1089/hum.1997.8.10-1243
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The aim of this study was to establish a nonviral method for gene delivery to the rat kidney. To this purpose, a panel of reagents was tested, including a monocationic lipid, DOTAP, a polycationic lipid, DOGS (or Transfectam), and three different forms of the cationic polymer polyethyleninine (PEI). A comparison among these compounds was performed in vivo, using luciferase as reporter gene. Complexes containing 10 mu g of DNA were injected into the left renal artery of rats and allowed to remain in contact with the kidney for 10 min. Forty-eight hours later, luciferase expression levels in kidney extracts were measured, Kidneys injected with DNA complexed to the branched, 25-kD PEI polymer (PEI 25k) yielded activity levels significantly higher than control, sham-operated kidneys (2.7 X 10(4) vs, 5.2 X 10(3) RLU/kidney, respectively), whereas the other transfecting agents did not yield significant activity over controls, PEI 25k was therefore chosen for further optimization of transfection conditions. Dose-dependent luciferase expression was shown for 10, 50, and 100 mu g of PEI-complexed DNA, reaching maximal levels of 2.4 X 10(5) RLU/kidney at 100 mu g DNA, The optimal PEI nitrogen/DNA phosphate molar ratio was 10 equivalents. Luciferase activity peaked at 2 days, was still significantly higher than controls at 7 days, and was undetectable at 14 days post-injection. Using beta-galactosidase (beta-Gal) as a reporter, transgene expression was localized almost exclusively in proximal tubular cells.
引用
收藏
页码:1243 / 1251
页数:9
相关论文
共 35 条
  • [11] GLAUMANN B, 1977, VIRCHOWS ARCH B, V24, P1
  • [12] POLYAMIDOAMINE CASCADE POLYMERS MEDIATE EFFICIENT TRANSFECTION OF CELLS IN CULTURE
    HAENSLER, J
    SZOKA, FC
    [J]. BIOCONJUGATE CHEMISTRY, 1993, 4 (05) : 372 - 379
  • [13] Heikkila P, 1996, GENE THER, V3, P21
  • [14] GLOMERULOSCLEROSIS INDUCED BY IN-VIVO TRANSFECTION OF TRANSFORMING GROWTH-FACTOR-BETA OR PLATELET-DERIVED GROWTH-FACTOR GENE INTO THE RAT-KIDNEY
    ISAKA, Y
    FUJIWARA, Y
    UEDA, N
    KANEDA, Y
    KAMADA, T
    IMAI, E
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (06) : 2597 - 2601
  • [15] GENE-TRANSFER INTO THE RAT RENAL GLOMERULUS VIA A MESANGIAL CELL VECTOR - SITE-SPECIFIC DELIVERY, IN-SITU AMPLIFICATION, AND SUSTAINED EXPRESSION OF AN EXOGENOUS GENE IN-VIVO
    KITAMURA, M
    TAYLOR, S
    UNWIN, R
    BURTON, S
    SHIMIZU, F
    FINE, LG
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (02) : 497 - 505
  • [16] INTEGRATION OF EMBRYONIC NEPHROGENIC CELLS CARRYING A REPORTER GENE INTO FUNCTIONING NEPHRONS
    KOSEKI, C
    HERZLINGER, D
    ALAWQATI, Q
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1991, 261 (03): : C550 - C554
  • [17] CANCER GENE-THERAPY USING PLASMID DNA - PHARMACOKINETIC STUDY OF DNA FOLLOWING INJECTION IN MICE
    LEW, D
    PARKER, SE
    LATIMER, T
    ABAI, AM
    KUWAHARARUNDELL, A
    DOH, SG
    YANG, ZY
    LAFACE, D
    GROMKOWSKI, SH
    NABEL, GJ
    MANTHORPE, M
    NORMAN, J
    [J]. HUMAN GENE THERAPY, 1995, 6 (05) : 553 - 564
  • [18] MEYER KB, 1995, GENE THER, V2, P450
  • [19] Expression of recombinant human granulocyte colony-stimulating factor in CHO dhfr(-) cells: New insights into the in vitro amplification expression system
    Monaco, L
    Tagliabue, R
    Giovanazzi, S
    Bragonzi, A
    Soria, MR
    [J]. GENE, 1996, 180 (1-2) : 145 - 150
  • [20] MONACO L, 1994, BIOTECHNOL APPL BIOC, V20, P157